In this competing renewal application, the Principal Investigator wishes to expand his studies on immunotherapy for autoimmune disease by comparing selective anti-TCR therapy with less selective approaches targeting either class II MHC, adhesion molecules or cytokines. Three different models for the induction of relapsing EAE will be utilized; these include 1) spinal cord homogenate, 2) T-cell clones specific for MBP 1-11 and 3) superantigen.
Five specific aims are proposed.
Aim 1 is to determine whether highly selective anti-TCR therapy will succeed in clinical paradigms where """"""""epitope spreading"""""""" might occur.
Aim 2 is to determine whether non-selective anti-cytokine therapy or anti- adhesion molecule therapy will be beneficial in clinical paradigms where """"""""epitope spreading"""""""" does occur.
Aim 3 is to assess the role of the cytokines IL-4 and IL-10 in suppression of EAE.
In Aim 4, the role of a variety of adhesion molecules, cytokines, class II and CD4 in selective and non- selective homing to the CNS will be assessed.
Aim 5 is to assess the possibility of using DNA vaccination against TCR Vb for treatment of EAE. It is hoped that these studies will provide the basis for future clinical trials in MS patients.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Project (R01)
Project #
5R01NS018235-17
Application #
2668950
Study Section
Special Emphasis Panel (ZRG5-EI (01))
Program Officer
Kerza-Kwiatecki, a P
Project Start
1982-04-01
Project End
2002-02-28
Budget Start
1998-03-01
Budget End
1999-02-28
Support Year
17
Fiscal Year
1998
Total Cost
Indirect Cost
Name
Stanford University
Department
Neurology
Type
Schools of Medicine
DUNS #
800771545
City
Stanford
State
CA
Country
United States
Zip Code
94305
Kanter, Jennifer L; Narayana, Sirisha; Ho, Peggy P et al. (2006) Lipid microarrays identify key mediators of autoimmune brain inflammation. Nat Med 12:138-43
Fontoura, Paulo; Ho, Peggy P; DeVoss, Jason et al. (2004) Immunity to the extracellular domain of Nogo-A modulates experimental autoimmune encephalomyelitis. J Immunol 173:6981-92
Robinson, William H; Fontoura, Paulo; Lee, Byung J et al. (2003) Protein microarrays guide tolerizing DNA vaccine treatment of autoimmune encephalomyelitis. Nat Biotechnol 21:1033-9
Neuman de Vegvar, Henry E; Amara, Rama Rao; Steinman, Lawrence et al. (2003) Microarray profiling of antibody responses against simian-human immunodeficiency virus: postchallenge convergence of reactivities independent of host histocompatibility type and vaccine regimen. J Virol 77:11125-38
Pedotti, Rosetta; Sanna, Maija; Tsai, Mindy et al. (2003) Severe anaphylactic reactions to glutamic acid decarboxylase (GAD) self peptides in NOD mice that spontaneously develop autoimmune type 1 diabetes mellitus. BMC Immunol 4:2
Robinson, William H; Utz, Paul J; Steinman, Lawrence (2003) Genomic and proteomic analysis of multiple sclerosis. Opinion. Curr Opin Immunol 15:660-7
Hueber, Wolfgang; Utz, Paul J; Steinman, Lawrence et al. (2002) Autoantibody profiling for the study and treatment of autoimmune disease. Arthritis Res 4:290-5
Robinson, William H; Steinman, Lawrence; Utz, Paul J (2002) Proteomics technologies for the study of autoimmune disease. Arthritis Rheum 46:885-93
Robinson, William H; DiGennaro, Carla; Hueber, Wolfgang et al. (2002) Autoantigen microarrays for multiplex characterization of autoantibody responses. Nat Med 8:295-301
Robinson, William H; Steinman, Lawrence; Utz, Paul J (2002) Protein and peptide array analysis of autoimmune disease. Biotechniques Suppl:66-9

Showing the most recent 10 out of 52 publications